GR76990B - - Google Patents

Info

Publication number
GR76990B
GR76990B GR66962A GR820166962A GR76990B GR 76990 B GR76990 B GR 76990B GR 66962 A GR66962 A GR 66962A GR 820166962 A GR820166962 A GR 820166962A GR 76990 B GR76990 B GR 76990B
Authority
GR
Greece
Application number
GR66962A
Original Assignee
Stering Drug
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stering Drug filed Critical Stering Drug
Publication of GR76990B publication Critical patent/GR76990B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GR66962A 1981-01-09 1982-01-08 GR76990B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/223,752 US4331671A (en) 1981-01-09 1981-01-09 5-(Pyridinyl)-1H-benzimidazoles and 1-hydroxy-6-(pyridinyl)-1H-benzimidazoles and their cardiotonic use

Publications (1)

Publication Number Publication Date
GR76990B true GR76990B (el) 1984-09-04

Family

ID=22837840

Family Applications (1)

Application Number Title Priority Date Filing Date
GR66962A GR76990B (el) 1981-01-09 1982-01-08

Country Status (13)

Country Link
US (1) US4331671A (el)
EP (1) EP0056260A1 (el)
JP (1) JPS57136583A (el)
KR (1) KR830009085A (el)
AU (1) AU7919082A (el)
CA (1) CA1188303A (el)
DK (1) DK4982A (el)
FI (1) FI820051L (el)
GR (1) GR76990B (el)
IL (1) IL64701A (el)
NO (1) NO820036L (el)
PT (1) PT74254B (el)
ZA (1) ZA8261B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432979A (en) * 1981-10-26 1984-02-21 William H. Rorer, Inc. Pyridone compounds
US4430502A (en) * 1982-08-13 1984-02-07 The Upjohn Company Pyridinyl substituted benzimidazoles and quinoxalines
SE8804628D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New compounds
US6162804A (en) * 1997-09-26 2000-12-19 Merck & Co., Inc. Tyrosine kinase inhibitors
US6465484B1 (en) 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
KR101036391B1 (ko) * 2003-03-13 2011-05-23 이데미쓰 고산 가부시키가이샤 신규한 질소 함유 헤테로환 유도체 및 이를 이용한 유기 전기발광 소자
JP4887194B2 (ja) * 2007-03-28 2012-02-29 株式会社ダイヘン 溶接ロボットのロボット制御装置
AU2016315881B2 (en) * 2015-09-03 2019-09-19 The Arizona Board Of Regents On Behalf Of The University Of Arizona Small molecule inhibitors of DYRK1A and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026936A (en) * 1975-08-07 1977-05-31 Hoffmann-La Roche Inc. Anthelmintic pyridine and thiazole substituted benzimidazole carbamates
GB1584296A (en) * 1976-12-07 1981-02-11 Kanebo Ltd 2-substituted benzimidazole compounds

Also Published As

Publication number Publication date
PT74254A (en) 1982-02-01
KR830009085A (ko) 1983-12-17
AU7919082A (en) 1982-07-15
EP0056260A1 (en) 1982-07-21
JPS57136583A (en) 1982-08-23
PT74254B (en) 1983-06-27
FI820051L (fi) 1982-07-10
CA1188303A (en) 1985-06-04
US4331671A (en) 1982-05-25
NO820036L (no) 1982-07-12
IL64701A0 (en) 1982-03-31
DK4982A (da) 1982-07-10
ZA8261B (en) 1982-11-24
IL64701A (en) 1984-10-31

Similar Documents

Publication Publication Date Title
DE3220218C2 (el)
DE3205046C2 (el)
DE3235288C2 (el)
DE3220606C2 (el)
FR2498963B1 (el)
DE3137191C2 (el)
FR2498784B1 (el)
DE3128412C2 (el)
FR2498979B1 (el)
DE3228541C2 (el)
CH653516GA3 (el)
DE3105217C2 (el)
DE3211612C2 (el)
DE3150396C2 (el)
DE3203831C2 (el)
FR2499625B3 (el)
DE3207808C2 (el)
FR2498139B1 (el)
FR2499763B3 (el)
FR2499341B1 (el)
FR2498077B3 (el)
DE3128565C2 (el)
CH655541B (el)
DE3221625C2 (el)
FR2498873B1 (el)